Menin inhibitors were reported to prevent the transformation of Npm1-mutated mouse hematopoietic progenitors into leukemic cells, implying that they could also be effective in Npm1-mutated preleukemia [96]. The gene discussed is NPM1; the disease is myelodysplastic syndrome.